Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07555041

Correlation Between Capillary Refill Time and Perfusion Index in Critically Ill Patients

Assessment of capillary refill time (CRT) is a cornerstone of tissue perfusion monitoring in critically ill patients.

CRT measurement is performed by applying brief and gentle pressure (for a few seconds) to a small area of skin until blanching occurs. CRT is defined as the time, in seconds, required for the skin surface to return to its initial color after release of pressure.

Although CRT is a monitoring tool used on a daily basis in emergency departments and critical care units, its practical measurement modalities remain poorly standardized and time-consuming. Consequently, there is no consensus regarding the most reproducible bedside method for CRT assessment. Moreover, repeated CRT measurements during patient management are resource-intensive in terms of medical time and may raise issues related to healthcare staff availability.

The perfusion index (PI) is a marker of tissue perfusion derived from a pulse oximetry sensor. This monitoring device is routinely used in all critically ill patients. It is placed on the finger and worn continuously, including during patient transport.

Because PI measurement is automatic and continuous, establishing its correlation with CRT could allow for more precise tissue perfusion monitoring while reducing the time burden associated with bedside assessments in critically ill patients.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Service de Réanimation cardio-vasculaire et thoracique, Hôpital Cardiologique louis Pradel, Hospices Civils de Lyon, Bron, France

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patient.
  • Admission within the previous 24 hours, or within 24 hours of the onset of a hemodynamic instability criterion (requirement for vasopressors or fluid resuscitation).
  • Absence of patient objection.

Exclusion criteria

  • Legal guardianship, curatorship, or judicial protection.
  • No social security coverage.
  • Morphological abnormalities preventing CRT and IP measurements.

Treatment and study plan

Microcirculation monitoring

Other

Microcirculation monitoring by Capillary Refill Time (CRT) measurements

Other names: Capillary refill time (CRT) measurements

Primary outcomes

  1. Perfusion index (PI) threshold associated with abnormal capillary refill time (CRT)

    Time frame: At the inclusion

    The primary endpoint will be the PI threshold associated with abnormal CRT (> 3 seconds).

    CRT is measured in seconds and PI in arbitrary units. These parameters will be measured simultaneously on each patient.

    Measurements will be performed at the inclusion of each patient.

Study contacts

Contact information is provided by the study sponsor or research team.

Martin COUR, MD

CONTACT

[email protected]

4 72 11 28 50 ext. +33

Neven STEVIC, MD

CONTACT

[email protected]

4 72 11 28 62 ext. +33

Sponsors and collaborators

Lead sponsor

Hospices Civils de Lyon

Other

Registry information

Official study title

Correlation Between Capillary Refilling tIme and Perfusion Index in Critically Ill Patients

Acronym: CRIPI

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Apr 28, 2026
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.